Aldeyra Therapeutics, Inc.

ALDXCIK 0001341235 · Every Form 4 filed by insiders at this issuer.

Filings

3

Latest Mar 12, 2024

Unique insiders

3

Showing

3 of 3

Page 1

Top insiders

Most active reporters at Aldeyra Therapeutics, Inc.

NameRolesFilings
Brady Todd C
OfficerDirector
1
Greenberg Bruce
Officer
1
Machatha Stephen
Officer
1

All filings

3 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 12, 2024
Brady Todd C
President and CEO · Director
S97,914$3.2735$320,521
Mar 12, 2024
Machatha Stephen
Chief Development Officer
S18,231$3.4064$62,102
Mar 12, 2024
Greenberg Bruce
See Remarks
S13,201$3.4064$44,968

Showing 13 of 3

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.